Abstract
I. Introductıon
Epilepsy is a complex neurological disorder affecting about 50 million people of all ages, races, and social classes [1] [2] [3] . The life long consumption of antiepileptic drugs and their divers side predisposes the risk of drug-drug interaction [4, 5] . Valproic acid (VPA) is a leading antiepileptic drug for the treatment of various types of epileptic seizures especially generalized seizures. One of its main advantages over benzodiazepines is the lack of sedative effect. However, in spite of the broad spectrum antiepileptic activity, the clinical use of VPA, is restricted by serious side effects like teratogenicity and hepatotoxicity [6] . Valproic acid is used as lead compound for developing new improved agents with potential anticonvulsant activity such as propylisopropyl acetamide (PID), valrocemide (VGD) and valnoctamide (VCD) (Figure 1 ) [7, 8] . Hydrazide-hydrazones derivatives enjoy various pharmaceutical activities e.g. antibacterial, antifungal, antimicrobial, anticancer and anticonvulsant activity [9, 10] . Therefore, a set of valproic acid analogues containing heteroatomic system were synthesized and screened for their anticonvulsant activity using pentylenetetrazole (PTZ)-induced eizures model. The cytotoxicity of compounds 3, 7e, 7j 10 and 11 was assessed by measuring their effecr on the viability HepG2 cell lines were evaluated. The effect of the compounds on the morphology of treated hepatocellular carcinoma cells was also investigated using the light microscope. 
General procedures for synthesis of hydrazones (7a-k)
To a solution of the hydrazide 5 (0.5 gm, 3.2 mmol) in ethanol (20 mL), the appropriate aldehyde (3.2 mmol) and acetic acid (two drops) were added. The reaction was refluxed for 2 hour. Then it was cooled and quenched with ice. The separated solid was filtered, and recrystallized from ethanol. -N'-(pyridin-4-ylmethylene) 
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Procedure for preparation of N-phenyl-2-(2-propylpentanoyl)hydrazine-1-carbothioamide (9)
A mixture of 5 (0.5 gm, 3.2 mmol) in ethanol (10 mL) and phenyl isothiocyanate (3. 
Procedure for preparation of 3-mercapto-4-phenyl-5-[1-(1-propyl)-1-butyl]-4H-1,2,4-triazole (10)
A mixture of 9 (0.5 gm, 1.7 mmol) in ethanol (10 mL) and sodium hydroxide (1.7 mmol) was refluxed for 6 hours. The solution is neutralized using glacial acetic acid and the precipitate was filtered, washed with water and crystallized from Chloroform/Petroleum ether (4:1 -5-[1-(1-propyl)-1-butyl]-1,3,4-thiadiazole (11) Compound 9 (0.5 gm, 1.7 mmol) was added to an ice cold sulphuric acid (5 mL) portionwise while stirring. The mixture was stirred for 24 hours then, poured on ice and neutralized with 10 M sodium carbonate. 
Procedure for preparation of 2-Phenylamino
Anticonvulsant activity
Adult male white Swiss albino mice weighing 20-25 g (10-12 weeks old) were obtained from Experimental Animal Care Centre, National Research Centre, Dokki, Giza, Egypt. The animals were maintained under standard conditions of humidity, temperature (25 ± 2 o C) and light (12 h light/12 h dark). They were fed with a standard mice pellet diet and had free access to water. Each treatment group and vehicle control group consisted of six animals. The anticonvulsant activity of compounds 3, 5, 7a-k, 10 and 11 was evaluated by pentylentetrazole (PTZ) models (12) . The test compounds were dissolved 10% DMSO Solution of compounds 3, 5, 7a-k, 10 and 11 was injected intraperitoneally (i.p.) at dose of 0.5 mmol/kg 30 minutes before seizures
Targets 7a-k, 10, 11 were subjected to standard subcutaneous pentetrazol (scPTZ) tests for anticonvulsant activity (12) . The results of the scPTZ screening in mice after intraperitoneal administration of the compounds are summarized in Table 2 . Compounds 7e, 7j, 10, 11 were proved to be active anticonvulsants at 0.5 mmol/kg. Compounds 7e, 7j, 10, 11 were subjected to further investigations at different doses for the quantification of their anticonvulsant activity (indicated by ED 50 ) in rats (Table 3) . Compounds 7e, 7j, 10, 11 were showed anticonvulsant activity against PTZ-induced seizure with ED 50 values of 268, 115, 133 and 187 mg/kg, respectively. Sodium valproate was used as reference drug at ED 50 value 300 mg/kg. Interestingly, the ED 50 value of standard reference drug was found higher than the test compounds at molar doses. The LD 50 and protective index of the test compounds were also determined ( Table 2) . It is noteworthy, that the protective index of the test compounds was found higher as compared to the reference anticonvulsant drug (Sodium valproate) at molar doses (Table 2) .
Cytotoxicity studies
The cytotoxicity of all the synthesized compounds was also studied against hepatoma cell line (HepG2) at 12.5, 50, 100, 200, and 400 μM concentrations using MTT assay colorimetric assay (Table 4) . 24 Data illustrated in (Figure 2) shows the percentage of viability of HepG2 cells after 48 h from treatment with different concentrations of the compounds versus control. The results revealed that the inhibition of HepG2 cells proliferation was in a dose dependent manner, as increasing the concentration of the tested compound lead to increase in cell growth inhibition (Figure 3) , which also was confirmed by morphology of the cells (Figure 3a &  3b) . The cells underwent dramatic morphological changes, shrunken and the ratio of cytolysis increased after exposure to tested compounds at 200 µM and 400 µM; where compound 7e had the lowest IC 50 value (44 µM), followed by compounds 7j and 10, with IC 50 values equal 81.3, and 172 µM, respectively (Table 4) . On the other hand, compounds 3 and 11 showed lower cytotoxicity, with high IC 50 value < 400 µM compared to 5-Flurouracil (5-FU) (with IC 50 =188 µM), which used as reference drug.
DOI: 10.9790/5736-1005023340 www.iosrjournals.org 39 |Page Figure 2 . Cytotoxic effect of the tested compounds on HepG 2 cells: different concentration of compounds starting from 12,5 to 400 µM were prepared. 1x10 4 cell/well of HepG 2 cells were treated with different concentration of tested compound for 48 h and cytotoxic effect was detected by MTT assay. The figure shows the % of cell growth viability compared to control which were untreated cell. 
IV. Conclusion
In conclusion, novel derivatives of valproic acid were constructed and evaluated for their anticonvulsant activity in mice. Four compounds 7e, 7j, 10 and 11 showed good anticonvulsant activty. Compound 11 showed anticonvulsant activity comparable to that of valproic acid and exhibited significantly lower cytotoxicity than valproic acid. Thus it could be used as a lead compound for further investigations.
